Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.912,08
-0,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sienna Biopharmaceuticals Inc (SNNA) Sienna Biopharmaceuticals Inc (SNNA) Notizie

SNNA

Sienna Biopharmaceuticals (SNNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNNA
DataOraFonteTitoloSimboloCompagnia
07/02/202017:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/02/202016:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/01/202014:00PR Newswire (US)Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna BiopharmaceuticalsNASDAQ:SNNASienna Biopharmaceuticals Inc
17/12/201912:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922:46Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922:40Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922:36Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201912:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201922:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201914:30GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting NoticeNASDAQ:SNNASienna Biopharmaceuticals Inc
12/11/201922:42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNNASienna Biopharmaceuticals Inc
07/10/201914:30GlobeNewswire Inc.Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L...NASDAQ:SNNASienna Biopharmaceuticals Inc
04/10/201920:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNNASienna Biopharmaceuticals Inc
17/09/201914:30GlobeNewswire Inc.Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection ProceedingNASDAQ:SNNASienna Biopharmaceuticals Inc
05/08/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic AlternativesNASDAQ:SNNASienna Biopharmaceuticals Inc
20/06/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
10/06/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal T...NASDAQ:SNNASienna Biopharmaceuticals Inc
21/05/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit EuropeNASDAQ:SNNASienna Biopharmaceuticals Inc
14/05/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, in...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/05/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BAML Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
08/05/201922:05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports First Quarter 2019 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201914:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201914:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
03/04/201923:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNNASienna Biopharmaceuticals Inc
21/03/201921:05GlobeNewswire Inc.Sienna Biopharmaceuticals Promotes Alexander Azoy to Chief Financial Officer and Appoints Sean Andrews to Leadership Team as ...NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914:19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914:05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
06/03/201922:41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/03/201915:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Cowen and Company Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNNA

La tua Cronologia

NASDAQ
VBOCU
Viscogliosi Brothers Acq...
EU
6477T
6477T
BOV
VRSN34
Verisign
ASX
JHCKOC
BOV
PETRQ36
PETRQ36 Ex:33,62
HUOB
NTUSDT
NEXTYPE
BIT
P1H4M1
BNP Paribas Issuance
GATE
CHNGBTC
Chainge Finance
ASX
ISLM
Equity Trustees
LSE
0MG2
Heidelberg Materials
AMEX
DWCR
Arrow DWA Tactical Inter...
BOV
FIQE3M
Unifique Telecomunicacoes ON
USOTC
BZLYF
Beazley (PK)
NASDAQ
MSFL
GraniteShares 2X Long MS...
USOTC
MERVF
Manila Electric (PK)
NASDAQ
SIDU
Sidus Space
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network